| Dr Sudhir Sekhsaria, MD | |
|
5430 Campbell Blvd, Suite 103, White Marsh, MD 21162-5500 | |
| (410) 933-9404 | |
| (410) 933-9405 |
| Full Name | Dr Sudhir Sekhsaria |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 41 Years |
| Location | 5430 Campbell Blvd, White Marsh, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568423606 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | D0038106 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Family Ent Allergy And Asthma Center Pc | 2365480209 | 3 |
| Asthma Allergy And Sinus Center, Llc | 2062406085 | 2 |
| Sudhir Sekhsaria M. D. P.c. | 7911186499 | 5 |
News Archive
Tasigna (nilotinib) capsules have been approved with conditions in Canada as a new therapy for patients with CML, in the chronic phase (first phase) of the disease. Patients must be resistant to or intolerant of at least one prior therapy, including (Pr)Gleevec (imatinib mesylate), an established standard of care.
Men with a history of obesity in their late teens are, in adult life, more at risk of a blood clot (thrombus) in a leg or lung, according to a study from the University of Gothenburg study shows.
Milwaukee teens are part of the White House Office of National Drug Control Policy's new, nationwide campaign encouraging teens to engage in a conversation about the positive and negative pressures that influence their decisions. The Influence Project is part of a new initiative of the anti-drug teen brand, Above the Influence, which emphasizes what teens do to resist drug use and stay "above" negative influences.
Since 2014 dulaglutide has been approved alone or in combination with other drugs for the treatment of adults with type 2 diabetes. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapies.
› Verified 5 days ago
| Entity Name | Family Ent Allergy And Asthma Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659396703 PECOS PAC ID: 2365480209 Enrollment ID: O20050420001230 |
News Archive
Tasigna (nilotinib) capsules have been approved with conditions in Canada as a new therapy for patients with CML, in the chronic phase (first phase) of the disease. Patients must be resistant to or intolerant of at least one prior therapy, including (Pr)Gleevec (imatinib mesylate), an established standard of care.
Men with a history of obesity in their late teens are, in adult life, more at risk of a blood clot (thrombus) in a leg or lung, according to a study from the University of Gothenburg study shows.
Milwaukee teens are part of the White House Office of National Drug Control Policy's new, nationwide campaign encouraging teens to engage in a conversation about the positive and negative pressures that influence their decisions. The Influence Project is part of a new initiative of the anti-drug teen brand, Above the Influence, which emphasizes what teens do to resist drug use and stay "above" negative influences.
Since 2014 dulaglutide has been approved alone or in combination with other drugs for the treatment of adults with type 2 diabetes. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapies.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sudhir Sekhsaria, MD 5430 Campbell Blvd Ste 103, White Marsh, MD 21162-5503 Ph: (410) 933-9404 | Dr Sudhir Sekhsaria, MD 5430 Campbell Blvd, Suite 103, White Marsh, MD 21162-5500 Ph: (410) 933-9404 |
News Archive
Tasigna (nilotinib) capsules have been approved with conditions in Canada as a new therapy for patients with CML, in the chronic phase (first phase) of the disease. Patients must be resistant to or intolerant of at least one prior therapy, including (Pr)Gleevec (imatinib mesylate), an established standard of care.
Men with a history of obesity in their late teens are, in adult life, more at risk of a blood clot (thrombus) in a leg or lung, according to a study from the University of Gothenburg study shows.
Milwaukee teens are part of the White House Office of National Drug Control Policy's new, nationwide campaign encouraging teens to engage in a conversation about the positive and negative pressures that influence their decisions. The Influence Project is part of a new initiative of the anti-drug teen brand, Above the Influence, which emphasizes what teens do to resist drug use and stay "above" negative influences.
Since 2014 dulaglutide has been approved alone or in combination with other drugs for the treatment of adults with type 2 diabetes. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapies.
› Verified 5 days ago
Jonathan Matz, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 5430 Campbell Blvd Ste 103, White Marsh, MD 21162 Phone: 410-933-9404 Fax: 410-933-9405 | |
Dr. Manav Singla, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 5430 Campbell Blvd, Suite 103, White Marsh, MD 21162 Phone: 410-933-9404 Fax: 410-933-9405 |